|
|
Article: Antihistamine may slow pace of cognitive decline in Alzheimer's.(Geriatric Psychiatry)
- Article from:
- Clinical Psychiatry News
- Article date:
- September 1, 2008
CopyrightCOPYRIGHT 2008 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CHICAGO -- An off-the-market antihistamine previously shown to slow cognitive decline over 1 year in Alzheimer's patients continued to preserve cognition and memory during a 6-month open-label extension trial.
The drug, dimebon, also stabilized cognition in patients who started on it after taking placebo during the original trial, Dr. Jeffrey Cummings said at the International Conference on Alzheimer's Disease.
"People initially treated with placebo and then crossed over to dimebon did not show the same level of benefit as those people who took dimebon for 18 months after starting the [initial] study," said Dr. Cummings, the Augustus S. Rose Professor ...